Pacira BioSciences Reports Real-World Study Showing EXPAREL® Use Was Associated with Reduced Opioid Use and Healthcare Costs in Patients Undergoing Total Shoulder Arthroplasty
Go back to Pacira BioSciences Reports Real-World Study Showing EXPAREL® Use Was Associated with Reduced Opioid Use and Healthcare Costs in Patients Undergoing Total Shoulder Arthroplasty| PACIRA (NASDAQ: PCRX) | Delayed: 23.05 +0.34 (1.50%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $22.71 | 52 Week High | $80.25 | |||
| Open | $22.90 | 52 Week Low | $30.25 | |||
| Day High | $23.21 | P/E | N/A | |||
| Day Low | $22.81 | EPS | $-2.08 | |||
| Volume | 67,308 | |||||
